Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Wall

Showing results (191-200 of 200) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 200 results.
Biologicals : Journal of the International Association of Biological Standardization|September 13, 2025
Report of the fourth conference on next-generation sequencing (NGS) for adventitious virus detection in biologics for humans and animals: Validation and implementation of NGSArifa S Khan, Laurent Mallet, Johannes Blümel, et al.
American Journal of Ophthalmology|March 28, 2007
Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension (pseudotumor cerebri)Anthony B Daniels, Grant T Liu, Nicholas J Volpe, et al.
Anesthesia and Analgesia|August 11, 2022
Nationwide Clinical Practice Patterns of Anesthesiology Critical Care Physicians: A Survey to Members of the Society of Critical Care AnesthesiologistsShahzad Shaefi, Ameeka Pannu, Ariel L Mueller, et al.
Bioorganic & Medicinal Chemistry Letters|November 23, 2018
Development and characterization of a CNS-penetrant benzhydryl hydroxamic acid class IIa histone deacetylase inhibitorChristopher A Luckhurst, Omar Aziz, Vahri Beaumont, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 13, 2006
Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitisEli O Meltzer, Frank C Hampel, Paul H Ratner, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|July 16, 2003
High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trialRoy W Beck, Jonathan D Trobe, Pamela S Moke, et al.
Archives of Neurology|September 15, 2004
Neurologic impairment 10 years after optic neuritisRoy W Beck, Craig H Smith, Robin L Gal, et al.
American Journal of Ophthalmology|January 1, 2004
Visual function more than 10 years after optic neuritis: experience of the optic neuritis treatment trialRoy W Beck, Robin L Gal, M Tariq Bhatti, et al.
Journal of Medicinal Chemistry|November 23, 2013
Design, synthesis, and biological evaluation of potent and selective class IIa histone deacetylase (HDAC) inhibitors as a potential therapy for Huntington's diseaseRoland W Bürli, Christopher A Luckhurst, Omar Aziz, et al.
Neurology|January 27, 2006
IM interferon beta-1a delays definite multiple sclerosis 5 years after a first demyelinating eventR Philip Kinkel, Craig Kollman, Paul O'Connor, et al.
Pageof 20

Showing results (191-200 of 200) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 200 results.
Biologicals : Journal of the International Association of Biological Standardization|September 13, 2025
Report of the fourth conference on next-generation sequencing (NGS) for adventitious virus detection in biologics for humans and animals: Validation and implementation of NGSArifa S Khan, Laurent Mallet, Johannes Blümel, et al.
American Journal of Ophthalmology|March 28, 2007
Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension (pseudotumor cerebri)Anthony B Daniels, Grant T Liu, Nicholas J Volpe, et al.
Anesthesia and Analgesia|August 11, 2022
Nationwide Clinical Practice Patterns of Anesthesiology Critical Care Physicians: A Survey to Members of the Society of Critical Care AnesthesiologistsShahzad Shaefi, Ameeka Pannu, Ariel L Mueller, et al.
Bioorganic & Medicinal Chemistry Letters|November 23, 2018
Development and characterization of a CNS-penetrant benzhydryl hydroxamic acid class IIa histone deacetylase inhibitorChristopher A Luckhurst, Omar Aziz, Vahri Beaumont, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 13, 2006
Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitisEli O Meltzer, Frank C Hampel, Paul H Ratner, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|July 16, 2003
High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trialRoy W Beck, Jonathan D Trobe, Pamela S Moke, et al.
Archives of Neurology|September 15, 2004
Neurologic impairment 10 years after optic neuritisRoy W Beck, Craig H Smith, Robin L Gal, et al.
American Journal of Ophthalmology|January 1, 2004
Visual function more than 10 years after optic neuritis: experience of the optic neuritis treatment trialRoy W Beck, Robin L Gal, M Tariq Bhatti, et al.
Journal of Medicinal Chemistry|November 23, 2013
Design, synthesis, and biological evaluation of potent and selective class IIa histone deacetylase (HDAC) inhibitors as a potential therapy for Huntington's diseaseRoland W Bürli, Christopher A Luckhurst, Omar Aziz, et al.
Neurology|January 27, 2006
IM interferon beta-1a delays definite multiple sclerosis 5 years after a first demyelinating eventR Philip Kinkel, Craig Kollman, Paul O'Connor, et al.
Pageof 20